학술논문
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Document Type
Article
Author
Yu, L.-M.; Dorward, J.; Hayward, G.; Gbinigie, O.; Van Hecke, O.; Ogburn, E.; Patel, M.G.; Harris, V.; Shanyinde, M.; de Lusignan, S.; Hobbs, F.D.R.; Butler, C.C.; Bafadhel, M.; Andersson, M.I.; Russell, R.E.K.; Nicolau, D.V.; Richards, D.; Saville, B.R.; Berry, N.; Detry, M.A.; Saunders, C.; Fitzgerald, M.; Evans, P.H.; Thomas, N.P.B.; Barnes, P.J.; Ramakrishnan, S.; Thomas, N.P.; Saunders, C.T.; Russell, R.E.
Source
In: The Lancet . (The Lancet, 4 September 2021, 398(10303):843-855)
Subject
Language
English
ISSN
1474547X
01406736
01406736